EDGAR Filing Documents for 0001193125-17-154081

Form 8-K - Current report:

SEC Accession No. 0001193125-17-154081

Filing Date

2017-05-02

Accepted

2017-05-02 16:38:05

Documents

Period of Report

2017-05-02

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d384951d8k.htm	8-K	38579
2	EX-4.1	d384951dex41.htm	EX-4.1	597661
3	EX-4.3	d384951dex43.htm	EX-4.3	40361
4	EX-99.1	d384951dex991.htm	EX-99.1	9276
5	EX-99.2	d384951dex992.htm	EX-99.2	11151
6	GRAPHIC	g384951dsp64a.jpg	GRAPHIC	2427
7	GRAPHIC	g384951dsp64b.jpg	GRAPHIC	2969
8	GRAPHIC	g384951dsp66.jpg	GRAPHIC	2257
9	GRAPHIC	g384951dsp67.jpg	GRAPHIC	3255
10	GRAPHIC	g384951dsp69.jpg	GRAPHIC	2593
11	GRAPHIC	g384951dsp70.jpg	GRAPHIC	3872
12	GRAPHIC	g384951g0501211208612.jpg	GRAPHIC	2943
13	GRAPHIC	g384951g0501214843880.jpg	GRAPHIC	2943
	Complete submission text file	0001193125-17-154081.txt		731611

Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803

Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777

Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)